Atlas Trials

EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase

Clinical trial NCT06894173 · RECRUITING

Trial details

NCT number
NCT06894173
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-12-03
Primary completion
2025-12-03
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.